announced today that newly published data from a multicenter, prospective trial show that sacral nerve stimulation using Medtronic InterStim® Therapy reduced incontinent episodes and increased quality ...
ELITE Study Designed to Confirm Long-Term Safety, Efficacy and Patient Benefit of Sacral Neuromodulation with the InterStim™ Micro System for Treatment of Overactive Bladder, Fecal Incontinence and ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...
A new multicenter study shows use of Medtronic’s InterStim Therapy via sacral nerve stimulation reduced incontinent episodes and improved quality of life in most patients with chronic fecal ...
Medtronic (NYSE:MDT) today announced the enrollment of the first patient in its ENDURANCE post-approval study of its Altaviva ...
Medtronic Inc. said Friday that it has received Food and Drug Administration approval for an implantable device to help patients better control their bowel movements. The product, called InterStim ...
Diarrhea and constipation are common causes of fecal incontinence. Dietary changes and medications can help improve fecal incontinence. Eating smaller meals and going to the bathroom often may prevent ...